Orrick Advises ANI Pharmaceuticals on Acquisition of Fluconazole Tablets


Orrick has advised ANI Pharmaceuticals on its acquisition of Fluconazole Tablets from a private company for $3 million. With this acquisition, ANI will further advance its strategy of expanding its product portfolio. The Orrick team advising ANI included David Schwartz, David Gold and Jamie Kamen.